John Koreth

18.4k total citations · 4 hit papers
199 papers, 9.3k citations indexed

About

John Koreth is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, John Koreth has authored 199 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Hematology, 77 papers in Immunology and 53 papers in Oncology. Recurrent topics in John Koreth's work include Hematopoietic Stem Cell Transplantation (137 papers), Immune Cell Function and Interaction (54 papers) and Acute Myeloid Leukemia Research (45 papers). John Koreth is often cited by papers focused on Hematopoietic Stem Cell Transplantation (137 papers), Immune Cell Function and Interaction (54 papers) and Acute Myeloid Leukemia Research (45 papers). John Koreth collaborates with scholars based in United States, France and Canada. John Koreth's co-authors include Corey Cutler, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea, Vincent T. Ho, Philippe Armand, Haesook T. Kim, Jerome Ritz, Sean M. McDonough and Ken‐ichi Matsuoka and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

John Koreth

191 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

2011 809 citations John Koreth, Haesook T. Kim et al. profile →
Toward Improving Caenorhabditis elegans Phenome Mapping With an ORFeome-Based RNAi Library

2004 720 citations John Koreth et al. profile →
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

2009 604 citations John Koreth, Joseph H. Antin et al. profile →
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

2015 280 citations John Koreth, Joseph Pidala et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Koreth United States	51	5.9k	3.6k	2.0k	1.4k	1.4k	199	9.3k
Robert A. Brodsky United States	62	5.6k 1.0×	7.4k 2.1×	1.2k 0.6×	1.8k 1.3×	2.9k 2.1×	264	13.3k
Stephen R. Spellman United States	45	5.8k 1.0×	5.2k 1.5×	1.6k 0.8×	986 0.7×	1.1k 0.8×	265	9.2k
Inderjeet Dokal United Kingdom	54	2.0k 0.3×	1.3k 0.4×	814 0.4×	5.7k 4.1×	1.2k 0.9×	148	10.4k
Ivan Maillard United States	48	1.2k 0.2×	2.7k 0.8×	1.5k 0.7×	3.7k 2.7×	811 0.6×	152	8.1k
Arjan C. Lankester Netherlands	50	2.7k 0.5×	3.0k 0.8×	2.1k 1.1×	1.5k 1.1×	1.2k 0.9×	231	7.8k
Charlotte M. Niemeyer Germany	54	4.8k 0.8×	2.1k 0.6×	1.6k 0.8×	4.1k 3.0×	1.8k 1.3×	260	10.3k
C. Ellen van der Schoot Netherlands	57	5.9k 1.0×	2.4k 0.7×	1.4k 0.7×	2.8k 2.0×	2.0k 1.4×	332	11.5k
Stephen G. Emerson United States	46	3.6k 0.6×	4.0k 1.1×	1.7k 0.9×	2.1k 1.5×	1.4k 1.1×	117	8.2k
Monica Bessler United States	42	2.1k 0.4×	3.5k 1.0×	278 0.1×	2.3k 1.6×	1.4k 1.0×	115	7.0k
David B. Miklos United States	37	2.1k 0.4×	2.6k 0.7×	2.2k 1.1×	1.5k 1.0×	777 0.6×	224	6.5k

Countries citing papers authored by John Koreth

Since Specialization

Citations

This map shows the geographic impact of John Koreth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Koreth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Koreth more than expected).

Fields of papers citing papers by John Koreth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Koreth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Koreth. The network helps show where John Koreth may publish in the future.

Co-authorship network of co-authors of John Koreth

This figure shows the co-authorship network connecting the top 25 collaborators of John Koreth. A scholar is included among the top collaborators of John Koreth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Koreth. John Koreth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koreth, John, Jeremy Pantin, Shukaib Arslan, et al.. (2025). Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.. Blood. 146(Supplement 1). 274–274.

Wobma, Holly, Malika Kapadia, Haesook T. Kim, et al.. (2023). Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. Blood Advances. 7(16). 4647–4657. 8 indexed citations

Maurer, Katie, Vincent T. Ho, Corey Cutler, et al.. (2023). Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD. Blood Advances. 7(15). 3903–3915. 14 indexed citations

Johnson, P. Connor, Haesook T. Kim, Meghan E. Sise, et al.. (2023). Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(7). 455.e1–455.e9. 3 indexed citations

Shapiro, Roman M., Haesook T. Kim, Michela Ansuinelli, et al.. (2023). Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse. Blood Advances. 7(15). 4080–4088. 2 indexed citations

Ikegawa, Shuntaro, Haesook T. Kim, Gordon J. Freeman, et al.. (2022). Low Dose IL-2 Therapy in Patients with Chronic Gvhd Induces PD-1+treg That Are Highly Activated, Immune Suppressive, and Proapoptotic. Transplantation and Cellular Therapy. 28(3). S59–S60. 1 indexed citations

Bashir, Qaiser, Taiga Nishihori, Marcelo C. Pasquini, et al.. (2022). A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial. Transplantation and Cellular Therapy. 29(6). 358.e1–358.e7. 5 indexed citations

Maurer, Katie, Haesook T. Kim, Utkarsh Acharya, et al.. (2021). COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Advances. 5(3). 861–871. 24 indexed citations

Maurer, Katie, Haesook T. Kim, Carol Reynolds, et al.. (2021). Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution. Blood Advances. 5(23). 5140–5149. 20 indexed citations

10.

Chin, Kuo‐Kai, Haesook T. Kim, Vincent T. Ho, et al.. (2021). Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience. Transplantation and Cellular Therapy. 27(12). 990.e1–990.e7. 14 indexed citations

11.

Kim, Haesook T., Lindsey E. Roeker, Corey Cutler, et al.. (2019). Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(3). 529–539. 16 indexed citations

12.

Magenau, John, Steven C. Goldstein, Robert J. Soiffer, et al.. (2018). α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 131(12). 1372–1379. 83 indexed citations

13.

Kamihara, Yusuke, Édouard Forcade, John Koreth, et al.. (2017). Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd. Blood. 130(Suppl_1). 74–74. 2 indexed citations

14.

Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018. 10 indexed citations

15.

Koreth, John, Kristen E. Stevenson, Haesook T. Kim, et al.. (2012). Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology. 30(26). 3202–3208. 104 indexed citations

16.

Ballen, Karen K., John Koreth, Yi‐Bin Chen, Bimalangshu R. Dey, & Thomas R. Spitzer. (2011). Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood. 119(9). 1972–1980. 106 indexed citations

17.

Cutler, Corey, Haesook T. Kim, Gary Bradwin, et al.. (2010). Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial Injury. Biology of Blood and Marrow Transplantation. 16(8). 1180–1185. 60 indexed citations

18.

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2008). Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology. 26(35). 5767–5774. 80 indexed citations

19.

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2007). Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 109(10). 4586–4588. 318 indexed citations

20.

Danesh, John, John Koreth, Linda Youngman, et al.. (1999). Is Helicobacter pylori a Factor in Coronary Atherosclerosis?. Journal of Clinical Microbiology. 37(5). 1651–1651. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact